Author

Abby Mocherniak

Queen's University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Badr SokratiD· 1 shared Brian L. SchmidtiD· 1 shared Chloe J. PeachiD· 1 shared Dane D. JenseniD· 1 shared Divya BhansaliiD· 1 shared Gokul Sriman Thanigai ArasuiD· 1 shared Kam W. LeongiD· 1 shared Lucas T. Parreiras‐e‐SilvaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Badr SokratORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Nanomedicines targeting signaling of protease-activated receptor 2 in organelles provide sustained analgesia

Shavonne L. Teng, Rocco Latorre, Divya Bhansali, Parker K. Lewis, Rachel E. Pollard, Chloe J. Peach, Badr Sokrat, Gokul Sriman Thanigai Arasu, Tracy Chiu, Dane D. Jensen, Nestor Nivardo Jiménez-Vargas, Abby Mocherniak, Lucas T. Parreiras‐e‐Silva, Michel Bouvier, Matthew Bogyo, , Nigel W. Bunnett

This study shows that targeting protease-activated receptor 2 (PAR2) signaling in organelles using nanomedicines provides sustained analgesia in preclinical models of inflammatory bowel disease.

Proceedings of the National Academy of Sciences · Oct 7, 2025Peer-reviewedPhysiology